Placing of shares in BioArctic AB (SE) — SEK 833 million

Carnegie acted as sole bookrunner in the placing of 3,500,000 shares in BioArctic, at a subscription price of SEK 238 per share. BioArctic is a research-based biopharma company focusing on disease-modifying treatments for neurodegenerative diseases, such as Alzheimer’s disease, Parkinson’s disease and ALS.
October 2022.